Pituitary Tumor Surveillance: Pathogenic Correlation

Pituitary Tumor Surveillance: Pathogenetic Correlation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00599092

Enrollment

1250

Registered

2008-01-23

Start date

1997-01-01

Completion date

2050-12-01

Last updated

2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Tumor

Keywords

pituitary tumor, recurrence

Brief summary

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.

Detailed description

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* patients with confirmed pituitary disease

Exclusion criteria

* patients who do not have confirmed pituitary disease

Design outcomes

Primary

Measure	Time frame	Description
Overall Survival (Longevity)	20 years	Overall survival will be measured from study enrollment (or diagnosis, as applicable) to death from any cause. Survival status will be determined through electronic medical records and, if necessary, supplemented by publicly available death records (e.g., National Death Index).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORShlomo Melmed, MD

Cedars-Sinai Medical Center, Pituitary Center

Outcome results